Good news for those looking for free epinephrine auto-injectors: Walgreens is partnering with the pharmaceutical company Kaléo to offer AUVI-Q auto-injectors at no cost for commercially insured patients who are eligible for Kaléo's patient support programs. Even those with high deductible plans might be eligible, and if you don’t have insurance, Kaléo may be able to help you through its patient assistance program. The injectors will be delivered right to your home or doctor’s office and have the added benefit of providing audio step-by-step instructions on how to administer them. Check with your doctor and apply today from the link below!
Who is usually the first on the scene in any type of emergency? Law enforcement officials. It may come as a surprise to many that police officers are not allowed to administer epinephrine in an emergency, nor do they carry an EpiPen. New York State Senator Jim Tedisco is working to change this situation, since police officers now carry and administer Narcan for drug overdoses. It would be most helpful if you could email your state senator and representative to tell them of your support of Sen. Tedisco’s legislation, S.9153, to permit law enforcement officers to carry and administer EpiPens.
New York State Senator Jim Tedisco (R-Glenville) has called for legislation to close what he calls a “dangerous loophole” by adding law enforcement, who often are first to respond to emergencies, to the list of professionals who can treat people with life-threatening allergic reactions.
Tedisco wants to enable police officers and members of law enforcement to carry epinephrine auto-injector (EAI) devices to treat people in an emergency.
This is a very frightening article on what could happen to someone experiencing anaphylaxis on an airplane flight. If you have a known food allergy you most likely carry your own epinephrine auto-injector device, but if it’s a first time allergic reaction you will have to hope someone on the plane has one and will lend it to you. Otherwise there would need to be a doctor or nurse on the plane who knows how to administer epinephrine with a vial and syringe, and as this article testifies, even allergists were unsure of what the dosage should be according to someone’s age. We are all for efforts to require airlines to stock EAI devices just like they do automatic electronic defibrillators (AED).
Kellie Hopkins was buckled in for the plane ride on February 27 and about to watch a movie when she heard the public address announcement; the flight crew were asking for help from a medical professional.
Hopkins, a nurse, rushed from her seat and was soon attending to Luca, a 10-year-old from New York City, who had eaten one cashew. Though his mom, Francine Ingrassia, had never known her son to have a food allergy, Luca quickly began to experience chest pain, stomach pain and increased difficulty breathing.
Perhaps you’ve seen signs in schools saying “no latex allowed” which of course would include balloons. Allergies to latex can be very serious, so the Allergy & Asthma Network is designating Oct. 7-13 as Latex Allergy Awareness Week. In addition to providing educational resources, the Network is hosting a webinar on Oct. 11, 2018 at 4 p.m. EST. Called “Latex Allergy Myths & Truths: What the Evidence Reveals,” it will feature board-certified allergist and latex allergy expert Kevin Kelly, MD, of North Carolina Children’s Hospital.
VIENNA, VA (August 31, 2018) – Allergy & Asthma Network announces Latex Allergy Awareness Week is Sunday, Oct. 7 to Saturday, Oct. 13, 2018. The theme this year is “Latex Allergy Myths & Truths: What the Evidence Reveals.”
During Latex Allergy Awareness Week, the Network raises awareness about the condition, which affects 1 to 6 percent of the population, and distributes educational resources in print and online. The week is intended to highlight the many issues facing people with latex allergy as well as encourage doctors and patients to stay vigilant in efforts to fully understand the condition and eliminate exposure to latex everywhere.
At long last, a potentially less expensive epinephrine auto-injector (EAI) device may be available to consumers very soon. TEVA Pharmaceuticals has received US government approval for a generic version of the Epi-PenTM originally made and marketed by Mylan Pharmaceuticals. Additional generic devices are on their way as well. The existing market for EAI devices is very large; different brands competing against each other could lead to lower prices. Our association fully supports any and all efforts aimed at better regulating healthcare costs for all Americans.